Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2004
02/11/2004CN1473607A Composition for preventing and treating hyperlipidemia
02/11/2004CN1473598A Medicinal pill for treating gastritis and its producing process
02/11/2004CN1473594A Extract of Maka root
02/11/2004CN1473582A Chinese medicine burn paste and its producing method
02/11/2004CN1473572A Hyaluronic acid gel with iron ion and medicine used for preventing adhesion after operation
02/11/2004CN1473571A New medicinal use of liquorice polysaccharide and its medicinal preparation
02/11/2004CN1473570A External use medicine for curing tinea manuum and tinea pedis and its preparing method
02/11/2004CN1473569A Composite preparation of sodium para-aminosallicylate and trimethoprim
02/11/2004CN1473568A Medicinal composition containing Brufen for treating cold
02/11/2004CN1473567A Combined therapeutic method including acrivastine and antihypertensive
02/11/2004CN1473566A Combined therapeutic method including acrivastine and antihypertensive
02/11/2004CN1473565A Benzopyrany/derivatives and antiallergic agent
02/11/2004CN1473564A New use of manumycin
02/11/2004CN1473562A Mouth cavity quick dissolving quick disintegrating freeze-dried tablet and its preparing method
02/11/2004CN1473561A Quick-releasing talbet in vagina and its preparing method
02/11/2004CN1473560A Mouth cavity fast disintegrating tablet of Chinese medicine or natural medical matters and its preparing method
02/11/2004CN1137900C Extracting process of polygonapolyose
02/11/2004CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use
02/11/2004CN1137892C Preparation of N-9 substituted guanine compound
02/11/2004CN1137891C Process for preparing growth hormone cinogenic agent
02/11/2004CN1137890C 8-alkoxyquinolone carboxylic acid with excellent stability and process for producing same
02/11/2004CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them
02/11/2004CN1137888C Inhibitor of cysteninyl aspartic acid proteinase
02/11/2004CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
02/11/2004CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/11/2004CN1137883C Aromatic carboxylic acid ester, its production and use of same as medicaments
02/11/2004CN1137877C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in in urinary lithasis
02/11/2004CN1137716C Hair moistening liquid with functions of nourishing hair, restoring hair, stopping baldness and eliminating scurf
02/11/2004CN1137711C Cream for treating burns, scalds and sore ulcer and its preparation
02/11/2004CN1137702C Application of piper laetispicum acetic ethyl ester extract of Chinese herbal medicine in preparation of psychoactive drugs
02/11/2004CN1137697C Chinese patented medicine compound powder for treating tuberculosis and its preparing method
02/11/2004CN1137695C Plaster for curing hemiplegia and hypertension
02/11/2004CN1137692C Application of low-anticoagulant heparin and its derivatives in preparing medicines for preventing and treating liver fibrosis
02/11/2004CN1137691C heterogeneous contraception preparation based on natural estrogen
02/11/2004CN1137690C Pharmaceutical comined preparation, kit and method for hormonal contraception
02/11/2004CN1137689C Drug delivery compositions for stability of steroids
02/11/2004CN1137688C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
02/11/2004CN1137687C Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
02/11/2004CN1137686C Remedies for spinal canal stenosis
02/11/2004CN1137685C Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
02/11/2004CN1137684C Pharmaceutical composition stabilized with basic agent
02/11/2004CN1137683C Compound dihydroartemisinin as new antimalarial
02/11/2004CN1137682C Therapeutic agents
02/11/2004CN1137680C Aerosol compositions
02/11/2004CN1137679C 水溶性滴眼剂 Water-soluble eye drops
02/11/2004CN1137675C Disinfectant powder for feet and its preparing method
02/10/2004USRE38425 Semicarbazones having CNS activity and pharmaceutical preparations containing same
02/10/2004US6689922 Vitamin D analogues
02/10/2004US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
02/10/2004US6689906 Bicyclic amino acids as pharmaceutical agents
02/10/2004US6689901 Process and intermediates to prepare latanoprost
02/10/2004US6689897 Intermediates of CETP inhibitors
02/10/2004US6689889 Using n-acryloxyphenylaniline neomenthylamide
02/10/2004US6689888 Processes and intermediates useful in preparing β3-adrenergic receptor agonists
02/10/2004US6689886 Treatment of inflammation and other immune disorders
02/10/2004US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones
02/10/2004US6689816 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
02/10/2004US6689815 Intratumoral use of dinitrochorobenzene: composition and use of injections including particular applications
02/10/2004US6689814 Use of dialkyldialkylammonium halide for the preparation of a virucidal medicament intended to be administered by the systemic route
02/10/2004US6689813 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
02/10/2004US6689812 Can be administered with conventional drugs to treat psychiatric or central nervous disorders to improve their efficacy or reduce their side effects
02/10/2004US6689811 Method of using caffeic acid phenethyl ester and analogs thereof as radiation sensitizers
02/10/2004US6689810 Contacting mammalian cells with nitric oxide mediator, wherein nitric oxide mediator is selected from pyruvates, pyruvate precursors, alpha -keto acids having four or more carbon atoms, precursors of alpha -keto acids for therapy
02/10/2004US6689809 Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
02/10/2004US6689808 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
02/10/2004US6689807 Activating akt
02/10/2004US6689804 Imidazo-imidazole
02/10/2004US6689803 Administering anti-microtubule compound-containing, pharmaceutically acceptable formulation wherein anti-microtubule compound is paclitaxel for therapy and prophylaxis of surgical adhesions
02/10/2004US6689802 Polymorphs of an epothilone analog
02/10/2004US6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
02/10/2004US6689800 β3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof
02/10/2004US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same
02/10/2004US6689795 Methods for treating dementia due to HIV disease
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/10/2004US6689793 Piperidinylethyl-, phenoxyethyl-, and β-fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity
02/10/2004US6689790 Substituted triazolopyridine compounds
02/10/2004US6689788 Method and composition for treatment of inflammatory bowel disease
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics
02/10/2004US6689784 Controlling cell apoptosis
02/10/2004US6689783 Aryl oxime-piperazines useful as CCR5 antagonists
02/10/2004US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents
02/10/2004US6689779 Pyridine or pyrimidine substituted; antibacterial activity; low toxicity
02/10/2004US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives
02/10/2004US6689777 Depolymerizing hemozoin using 2-imino-naphtho(1,2-d)thiazol-5-ol derivatives
02/10/2004US6689774 Treating apoptosis. especially by administering zinc pyrithione, heterocyclic amines, dithiocarbamates and vitamins.
02/10/2004US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
02/10/2004US6689769 Bactericides
02/10/2004US6689768 Chemically modified derivatives of 17 alpha -estradiol, 17 beta -estradiol and estriol for reducing side effects during and/or after treatment with analogs or antagonist of gonadotropin releasing hormone
02/10/2004US6689767 Triterpenes having antibacterial activity
02/10/2004US6689765 Viricides; antiinflammatory agents
02/10/2004US6689764 Treatment of angiogenesis dependent conditions with dextrin sulphate
02/10/2004US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt
02/10/2004US6689759 Combined with nucleoside and/or nucleotide antiviral agents and immunostimulants
02/10/2004US6689756 Via catheter comprising antimicrobial agent and second catheter for withdrawing fluid; for treating infection or neoplasm of cerebrospinal tissue
02/10/2004US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution
02/10/2004US6689748 Method of treating mast cell activation-induced diseases with a proteoglycan
02/10/2004US6689593 Generation of farnesol; culture genetically engineered microorganism in nutrient broth, ferment in nutrient broth and recover farnesol
02/10/2004US6689588 Use in column containing the immobilized alliinase and collecting pure allicin in effluent; pure allicin has as food additive or pharmaceutical for infections, thrombosis or hyperlipidemia
02/10/2004US6689562 Mammalian IAP gene family, primers, probes and detection methods